Isolated tumor cell in lateral lymph node has no influences on the prognosis of rectal cancer patients

International Journal of Colorectal Disease

Volumn 22, Issue 8, 2007, Pages 911-917

  Hara, M ^a   Hirai, T ^a   Nakanishi, H ^a   Kanemitsu, Y ^a   Komori, K ^a   Tatematsu, M ^a   Kato, T ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Isolated tumor cell; Lateral lymph node dissection; Lateral lymph node metastasis; Rectal cancer

Indexed keywords

EOSIN; FLUOROURACIL; HEMATOXYLIN; KERATIN ANTIBODY;

ADULT; ARTICLE; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RECTUM RESECTION; STAINING; SURVIVAL RATE; TUMOR CELL;

ADULT; AGED; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EOSINE YELLOWISH-(YS); FEMALE; FOLLOW-UP STUDIES; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KERATINS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; STAINING AND LABELING; TREATMENT OUTCOME;

EID: 34250721573     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0280-4     Document Type: Article

References (34)

1. Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ (1999) Significance of true surgical pathologic staging: A Gynecologic Oncology Group Study. Am J Obstet Gynecol 181:31-34
2. Bochner BH, Herr HW, Reuter VE (2001) Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 166:2295-2296
3. Heidenreich A, Varga Z, Von Knobloch R (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis. J Urol 167:1681-1686
4. Bacon HE, Sauer I (1950) Surgical treatment of cancer of the lower bowel. Cancer 3:773-778
5. Stearns MW Jr, Deddish MR (1959) Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum 2:169-172
6. Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC, van de Velde CJ (1999) Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients. Eur J Surg Oncol 25:368-374
7. Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ (1998) Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 85:526-529
8. MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457-460
9. Delaney CP, Lavery IC, Brenner A, Hammel J, Senagore AJ, Noone RB, Fazio VW (2002) Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers. Ann Surg 236:203-207
10. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
11. Bonnel C, Parc YR, Pocard M, Dehni N, Caplin S, Parc R, Tiret E (2002) Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function. Dis Colon Rectum 45:934-939
12. Koyama Y, Moriya Y, Hojo K (1984) Effects of extended systematic lymphadenectomy for adenocarcinoma of the rectum-significant improvement of survival rate and decrease of local recurrence. Jpn J Clin Oncol 14:623-632
13. Sugihara K, Moriya Y, Akasu T, Fujita S (1996) Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome. Cancer 78:1871-1880
14. Mori T, Takahashi K, Yasuno M (1998) Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: The impact of lateral lymph node dissection. Langenbecks Arch Surg 383:409-415
15. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73:563-569
16. Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, Bruch HP, Duchrow M (1997) Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: An immunohistochemical study. Dis Colon Rectum 40:1465-1471
17. Isaka N, Nozue M, Doy M, Fukao K (1999) Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: An immunohistochemical study by CAM5.2. Clin Cancer Res 5:2065-2068
18. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172:183-187
19. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L (1996) Occurrence and prognostic importance ofmicrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: An immunohistochemical study. Eur J Surg 162:637-642
20. Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, da Silva JH, Goffi FS (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34:917-920
21. Shimoyama M, Yamazaki T, Suda T, Hatakeyama K (2003) Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: An immunohistochemical study with CAM5.2. Dis Colon Rectum 46:333-339
22. Sobin LH (2003) TNM: Evolution and relation to other prognostic factors. Sem Surg Oncol 21:3-7
23. Sobin LH (2003) TNM, sixth edition: New developments in general concepts and rules. Sem Surg Oncol 21:19-22
24. Hermanek P, Hutter RV, Sobin LH, Wittekind C (1999) International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 86:2668-2673
25. Sobin LH, Wittekind C (2002) TNM classification of malignant tumors, 6th edn. Wiley, New York
26. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S (2001) Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 8:300-304
27. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, Cummings B, Gunderson L, Macdonald JS, Mayer RJ (2001) Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19:157-163
28. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896-2900
29. Moriya Y, Hojo K, Sawada T, Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32:307-315
30. Fujita S, Yamamoto S, Akasu T, Moriya Y (2003) Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 90:1580-1585
31. Greene FL, Page D, Fleming ID (2002) AJCC Cancer staging manual, 6th edn. Springer, Berlin Heidelberg New York
32. Enker WE, Thaler HT, Cranor ML, Polyak T (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335-346
33. (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Lancet 345:939-944
34. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ et al (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 11:1879-1887